Jennifer J Thomas1,2, Kendra R Becker1,2, Megan C Kuhnle1,3, Jenny H Jo1,3, Stephanie G Harshman1,2,3, Olivia B Wons1,3,4, Ani C Keshishian1,5, Kristine Hauser3, Lauren Breithaupt1,2, Rachel E Liebman1,2,6, Madhusmita Misra2,3, Sabine Wilhelm2,7, Elizabeth A Lawson2,3, Kamryn T Eddy1,2. 1. Eating Disorders Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts, USA. 2. Harvard Medical School, Boston, Massachusetts, USA. 3. Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, USA. 4. Department of Psychology, Drexel University, Philadelphia, Pennsylvania, USA. 5. Department of Psychological and Brain Sciences, University of Louisville, Louisville, Kentucky, USA. 6. Department of Psychology, Ryerson University, Toronto, Ontario, USA. 7. Obsessive-Compulsive Disorder and Related Disorders Program, Richard B. Simches Research Center, Boston, Massachusetts, USA.
Abstract
OBJECTIVE: Little is known about the optimal treatment of avoidant/restrictive food intake disorder (ARFID). The purpose of this study was to evaluate feasibility, acceptability, and proof-of-concept for cognitive-behavioral therapy for ARFID (CBT-AR) in children and adolescents. METHOD: Males and females (ages 10-17 years) were offered 20-30 sessions of CBT-AR delivered in a family-based or individual format. RESULTS: Of 25 eligible individuals, 20 initiated treatment, including 17 completers and 3 dropouts. Using intent-to-treat analyses, clinicians rated 17 patients (85%) as "much improved" or "very much improved." ARFID severity scores (on the Pica, ARFID, and Rumination Disorder Interview) significantly decreased per both patient and parent report. Patients incorporated a mean of 16.7 (SD = 12.1) new foods from pre- to post-treatment. The underweight subgroup showed a significant weight gain of 11.5 (SD = 6.0) pounds, moving from the 10th to the 20th percentile for body mass index. At post-treatment, 70% of patients no longer met criteria for ARFID. DISCUSSION: This is the first study of an outpatient manualized psychosocial treatment for ARFID in older adolescents. Findings provide evidence of feasibility, acceptability, and proof-of-concept for CBT-AR. Randomized controlled trials are needed.
OBJECTIVE: Little is known about the optimal treatment of avoidant/restrictive food intake disorder (ARFID). The purpose of this study was to evaluate feasibility, acceptability, and proof-of-concept for cognitive-behavioral therapy for ARFID (CBT-AR) in children and adolescents. METHOD: Males and females (ages 10-17 years) were offered 20-30 sessions of CBT-AR delivered in a family-based or individual format. RESULTS: Of 25 eligible individuals, 20 initiated treatment, including 17 completers and 3 dropouts. Using intent-to-treat analyses, clinicians rated 17 patients (85%) as "much improved" or "very much improved." ARFID severity scores (on the Pica, ARFID, and Rumination Disorder Interview) significantly decreased per both patient and parent report. Patients incorporated a mean of 16.7 (SD = 12.1) new foods from pre- to post-treatment. The underweight subgroup showed a significant weight gain of 11.5 (SD = 6.0) pounds, moving from the 10th to the 20th percentile for body mass index. At post-treatment, 70% of patients no longer met criteria for ARFID. DISCUSSION: This is the first study of an outpatient manualized psychosocial treatment for ARFID in older adolescents. Findings provide evidence of feasibility, acceptability, and proof-of-concept for CBT-AR. Randomized controlled trials are needed.
Authors: Robert J Kuczmarski; Cynthia L Ogden; Shumei S Guo; Laurence M Grummer-Strawn; Katherine M Flegal; Zuguo Mei; Rong Wei; Lester R Curtin; Alex F Roche; Clifford L Johnson Journal: Vital Health Stat 11 Date: 2002-05
Authors: Anna Aulinas; Dean A Marengi; Francesca Galbiati; Elisa Asanza; Meghan Slattery; Christopher J Mancuso; Olivia Wons; Nadia Micali; Elana Bern; Kamryn T Eddy; Jennifer J Thomas; Madhusmita Misra; Elizabeth A Lawson Journal: Int J Eat Disord Date: 2020-03-21 Impact factor: 4.861
Authors: Helen Burton Murray; Kendra R Becker; Lauren Breithaupt; Melissa J Dreier; Kamryn T Eddy; Jennifer J Thomas Journal: Int J Eat Disord Date: 2022-07-02 Impact factor: 5.791
Authors: Angelique F Ralph; Leah Brennan; Sue Byrne; Belinda Caldwell; Jo Farmer; Laura M Hart; Gabriella A Heruc; Sarah Maguire; Milan K Piya; Julia Quin; Sarah K Trobe; Andrew Wallis; A J Williams-Tchen; Phillipa Hay Journal: J Eat Disord Date: 2022-08-18
Authors: Jennifer J Thomas; Kendra R Becker; Lauren Breithaupt; Helen Burton Murray; Jenny H Jo; Megan C Kuhnle; Melissa J Dreier; Stephanie Harshman; Danielle L Kahn; Kristine Hauser; Meghan Slattery; Madhusmita Misra; Elizabeth A Lawson; Kamryn T Eddy Journal: J Behav Cogn Ther Date: 2021-03-03
Authors: Eric Dumont; Anita Jansen; Pieter C Duker; Daniel M Seys; Nick J Broers; Sandra Mulkens Journal: Front Pediatr Date: 2022-05-03 Impact factor: 3.418
Authors: Mark L Norris; Nicole Obeid; Alexandre Santos; Darcie D Valois; Leanna Isserlin; Stephen Feder; Wendy Spettigue Journal: Front Psychiatry Date: 2021-07-16 Impact factor: 4.157